Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

This company has been moved to the archive! The financial data has not been updated since November 7, 2024.

Enterprise Value (EV) 

Microsoft Excel

Current Enterprise Value (EV)

Moderna Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $50.28
No. shares of common stock outstanding 384,817,811
US$ in millions
Common equity (market value)1 19,349
Add: Preferred stock, $0.0001; no shares issued or outstanding (per books)
Total equity 19,349
Add: Financing lease liabilities, current (per books)
Add: Financing lease liabilities, non-current (per books) 575
Total equity and debt 19,924
Less: Cash and cash equivalents 2,907
Less: Investments 5,697
Enterprise value (EV) 11,320

Based on: 10-K (reporting date: 2023-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 50.28 × 384,817,811


Historical Enterprise Value (EV)

Moderna Inc., EV calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Share price1, 2 $96.46 $139.26 $151.33 $154.81 $26.16
No. shares of common stock outstanding1 382,073,208 386,339,594 402,872,986 399,769,582 368,642,548
US$ in millions
Common equity (market value)3 36,855 53,802 60,967 61,888 9,644
Add: Preferred stock, $0.0001; no shares issued or outstanding (book value)
Total equity 36,855 53,802 60,967 61,888 9,644
Add: Financing lease liabilities, current (book value) 161 165 24
Add: Financing lease liabilities, non-current (book value) 575 912 599 110 39
Total equity and debt 37,430 54,875 61,731 62,023 9,682
Less: Cash and cash equivalents 2,907 3,205 6,848 2,624 236
Less: Investments 5,697 6,697 3,879 1,984 867
Enterprise value (EV) 28,826 44,973 51,004 57,415 8,579

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Moderna Inc. Annual Report.

3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 96.46 × 382,073,208


Equity and Market Value Trends
The common equity, measured at market value, experienced a significant increase from 9,644 million US dollars at the end of 2019 to a peak of 61,888 million by the end of 2020. This was followed by a slight decline to 60,967 million in 2021, and a continued reduction in the following years, reaching 36,855 million by the end of 2023. This trend suggests a substantial market capitalization expansion in 2020, likely driven by favorable conditions or company performance, followed by a gradual contraction over the subsequent three years.
Total Equity and Debt
Total equity closely mirrored the common equity figures throughout the period, indicating that total equity was effectively composed mainly of common equity. The total equity and debt figures also followed a similar trajectory, increasing sharply from 9,682 million in 2019 to 62,023 million in 2020, then gradually decreasing to 37,430 million by the end of 2023. This parallel movement suggests limited variance within the debt component relative to equity during these years.
Enterprise Value Evaluation
Enterprise value (EV), which provides a measure of the company's total value including debt and excluding cash, showed a marked increase from 8,579 million at the end of 2019 to 57,415 million in 2020. However, unlike the market value of equity, EV decreased consistently year over year afterward, falling to 28,826 million by the end of 2023. This reflects a potential decrease in overall company valuation and possibly changes in debt levels or market perceptions of company worth over the period.
Overall Financial Position Insights
The data indicates a peak in financial valuation and market optimism for the company around 2020, followed by a steady decline through 2023. The alignment between equity and total equity values suggests stable equity compositions without significant issuance or repurchase of different equity classes. The decline in both equity and enterprise value suggests possibly declining market confidence or operational challenges over the recent years covered.